CDBT — China Dasheng Biotechnology Co Income Statement

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Annual income statement for China Dasheng Biotechnology Co, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2005 October 31st	R2006 October 31st	2007 October 31st	2008 June 30th
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	10KSB	10KSB	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Revenue
Total Revenue	0.631	0	0	16.3
Cost of Revenue
Gross Profit	0.224	—	—	7.5
Selling / General / Administrative Expenses
Other Operating Expenses
Total Operating Expenses	0.654	0	0.01	11.2
Operating Profit	-0.023	0	-0.01	5.08
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-0.023	0	-0.01	5.19
Provision for Income Taxes
Net Income After Taxes	-0.015	0	-0.01	5.19
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-0.015	-0.017	-0.068	4.64
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.015	-0.017	-0.068	4.64
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.002	0	-0.001	0.155
Dividends per Share